Psychedelics Archives - Page 58 of 68

1 minute read

Magic Mushroom In A Pill? New Microdose Plans Enter Clinical Studies: Here’s What Scientists Want To Learn

September 29, 2:36 PM

Nova Mentis Life Science Corp. (OTCQB: NMLSF), a biotech company focused on creating psilocybin-based therapeutics produced 1.5 mg psilocybin microdose capsules compliant with the chemistry, manufacturing and controls (CMC) published guidelines.

NMLSF

1 minute read

MindMed To Raise Around $30M Via Public Offering

By Vuk Zdinjak

September 28, 8:23 AM

Mind Medicine Inc.

MNMD

1 minute read

Psychedelics Capital Markets: Silo Pharma’s IPO, $5M Common Stock Offering

By Lara Goldstein

September 27, 6:01 PM

Developmental-stage biopharma company Silo Pharma Inc. (NASDAQ: SILO) announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at $5.00 per share, to begin trading on NASDAQ on Tuesday, September 27, 2022 under trading symbol “SILO.”

SILO

2 minute read

Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives

By Lara Goldstein

September 27, 5:57 PM

In parallel with working towards discovering and advancing therapeutic psychedelics, biopharma companies are continuously protecting their findings.

BETRF

2 minute read

Cybin Acquires Exclusive License To Mindset Pharma’s Tryptamine Compounds Family

By Lara Goldstein

September 27, 2:20 PM

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

CYBN

2 minute read

Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System

By Lara Goldstein

September 27, 1:51 PM

Life and sciences R&D company Biomind Labs Inc.

BMNDF

2 minute read

EXCLUSIVE: Global Psychedelics Company Silo Wellness Acquires Dyscovry Science, Including Access To Its Gov Collaborations

By Javier Hasse

September 27, 6:50 AM

According to information procured exclusively by Benzinga ahead of an official announcement, global psychedelics company Silo Wellness Inc.

CSE:SILO

3 minute read

Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: How Are They Commercialized?

By Lara Goldstein

September 26, 4:23 PM

(Part four of a four-part series)

CMPS

2 minute read

Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?

By Lara Goldstein

September 26, 3:52 PM

Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP.

TRYPF

2 minute read

Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products

By Lara Goldstein

September 26, 3:41 PM

Life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories International Inc. for the manufacturing of its proprietary psychedelic active pharmaceutical ingredient (API) products.

CLABF